Most market-entry delays have nothing to do with the target market. They happen because the manufacturer arrives unprepared — missing documents, unclear pricing, no agreed service concept. The good news: everything on this list can be prepared before you spend a single euro abroad.

Documentation

1. Complete technical datasheets in English. Not marketing brochures — datasheets. Distributors, procurement departments, and researchers all read specifications before they read anything else.

2. Your certification file. CE, ISO, safety and EMC test reports, declarations of conformity. Gaps here are the single most common reason a first shipment gets stuck in customs or a tender bid gets disqualified.

3. A reference list you are allowed to use. Three named customers with permission to be mentioned are worth more than “hundreds of installations worldwide.”

Commercial framework

4. An export price list with defined margin room. If a distributor has to ask “what discount can I get?”, the negotiation starts on the wrong foot. Decide your floor before the first conversation.

5. Clear Incoterms and lead times. “EXW, 8 weeks” is a perfectly good answer. No answer is not.

6. A warranty and service concept. Who repairs the instrument, where, and who pays for shipping? In regulated environments this question decides deals.

Market focus

7. A defined target customer. “Everyone who uses a laboratory” is not a segment. “University research groups in materials science with mid-six-figure annual instrument budgets” is.

8. A realistic first-year goal. Pipeline built, first reference installation, first distributor signed — pick one primary objective. Trying to achieve all three at once usually achieves none.

9. A named internal owner. Market entry fails quietly when nobody inside the company is responsible for answering the local partner within 48 hours.

Preparation is not bureaucracy. It is the difference between a first meeting that ends with “send us more information” and one that ends with a next step.

If you can tick all nine boxes, you are ahead of most manufacturers we meet — and your market entry will move noticeably faster.

Every manufacturer entering a new market faces the same structural choice: sell through a distributor, sell directly, or establish local representation. None of the three is universally better — they trade control against speed against cost. Here is how to think about it.

The distributor route

A distributor buys, imports, stocks, and resells. You get immediate market access, local invoicing, and someone else carrying inventory risk. The price: margin (typically 25–40% for technical instruments) and distance from your end customers. You learn what the market wants second-hand, if at all.

Fits when: your product is standardized, service requirements are moderate, and speed matters more than market intelligence.

The direct sales route

You keep the full margin and full customer relationship — and take on everything that comes with it: local compliance, import, logistics, installation, support, and a sales presence in the right time zone and language. Done from headquarters, this usually means long sales cycles and customers who hesitate to buy from a company with no local footprint.

Fits when: deal sizes are large, the customer count is small, and you can afford a genuine local presence.

The local representative route

A middle path: a local partner generates leads, holds meetings, manages tenders, and coordinates delivery and support in your name — while contracts and invoices remain yours. You keep the customer relationship and the margin structure; the partner provides the local face, language, and network.

Fits when: you want to build a lasting market position under your own brand without the cost of a subsidiary.

Four questions that decide it

• Who must own the customer relationship? If the answer is “we do,” a classic distributor model will frustrate you.
• How much service does the product need? High service load favors partners with local technical capability.
• How fast do you need revenue? Distributors are fastest to first order; direct sales are slowest.
• What can you invest before payback? A subsidiary costs the most, a commission-based representative the least.

The most common mistake is not choosing the wrong model — it is refusing to choose, and running three half-models at once.

The models can also be staged: many of our partnerships start as a defined project, move to representation once the pipeline is real, and add distribution when order volume justifies local stock. Start with the model that matches where you are today, not where you hope to be in year three.

Universities, public research institutes, and hospitals buy a remarkable share of their equipment through formal tenders. The budgets are published, the requirements are written down, and the process is legally bound to be fair. On paper, it is the most transparent sales channel that exists. In practice, most foreign manufacturers never submit a single bid.

Why manufacturers stay away

The barriers are always the same three: the tender is published in the local language with short deadlines; the paperwork demands local registrations, tax certificates, and formal declarations that a foreign entity cannot easily produce; and the specifications seem to describe a competitor’s instrument suspiciously well.

All three are solvable — but not from a headquarters office five time zones away.

What winning actually takes

Be present before the tender exists. Specifications are written by people who have seen instruments demonstrated. If the first time a buyer hears your name is in your bid, you are bidding on requirements shaped around someone else’s product. Academic outreach and demo visits months earlier are not marketing overhead — they are tender preparation.

Monitor systematically. Tender portals are fragmented and deadlines are short. A local partner who watches the right portals weekly turns “we found it too late” into a non-issue.

Get the formalities flawless. Most disqualifications are administrative: a missing declaration, an uncertified translation, a late clarification response. This is exactly the part a local representative handles routinely.

Solve the service question in writing. Public buyers must justify their decision for years. A named local support arrangement — response times, spare parts, training — removes their biggest reason to score you down.

Tenders are not won in the two weeks before the deadline. They are won in the twelve months before the tender is published.

The math worth doing

A single public tender for laboratory instrumentation frequently exceeds a distributor’s entire annual order volume. If your product is competitive and you are not bidding, you are conceding the most predictable revenue in the market to whoever is.

Ask a manufacturer where their growth will come from and you will hear about distributors and trade fairs. Ask where their best customers came from, and surprisingly often the answer is: a researcher who used the instrument during their PhD and specified it again in every lab they joined afterwards.

That is not an accident. It is a channel — and almost nobody works it deliberately.

Why academia compounds

• Researchers publish. Every paper that names your instrument in its methods section is a permanent, credible, searchable reference — written by a customer, for free.
• Researchers move. Postdocs carry instrument preferences from Vienna to Boston to Singapore. One good installation seeds specifications in labs you have never visited.
• Researchers advise procurement. When a university buys, the requirement list is written by the scientists who will use the equipment. Being known to them is being specified.
• Grants are public. Funding databases announce who just received money for exactly the kind of work your instrument supports — months before any purchase happens.

What deliberate outreach looks like

Shortlist, don’t broadcast. Mass emails to university domains achieve nothing. The unit of work is a shortlist: research groups whose published work matches your instrument’s strengths, built from publication databases and grant announcements.

Lead with their research, not your product. The email that gets answered references the group’s recent paper and explains, in two sentences, what the instrument would change about their measurement. Nothing else.

Make a demo trivially easy. Loan units, sample measurements on the researcher’s own material, or a visit to an existing installation nearby — the goal is to get the instrument into their data, because their data ends up in their papers.

Stay present between purchases. Academic budgets move in waves (grant cycles, fiscal year-ends). A group that had no budget in March may have an approved instrument line in October. Presence is what makes you the call they make.

Academic outreach is slow the way compound interest is slow: unimpressive in any given month, decisive over three years.

For a manufacturer without a local team, this is also the channel a regional partner can run almost entirely on your behalf — shortlisting, first contact, demos, and follow-up — while every reference it produces belongs permanently to your brand.

Expanding too early burns cash on a market that was never ready for you. Expanding too late means watching a competitor’s logo appear in the reference lists you wanted. After enough market-entry projects, patterns emerge. Here are the signals we look for.

Signs you are ready

1. Unsolicited foreign inquiries. If buyers you never contacted are finding you — from conference papers, search, or word of mouth — demand exists. Inbound interest from a region is the cheapest market research you will ever get.

2. A stable, documented product. Shipping revision C while support still fields revision A questions is survivable at home, where you speak the language and know the customers. Abroad, it multiplies into chaos.

3. Reference customers who will take a call. International buyers discount your claims and trust your customers. Three references who genuinely like the product outweigh any brochure.

4. Margin that survives the journey. Export means freight, duties, certification costs, partner margin, and service reserves. If your home-market margin can absorb 30–40% of overhead and still leave profit, the economics work.

5. Internal capacity to respond. A local partner can open doors, but someone at headquarters must answer technical questions, issue quotes, and support demos — within days, not weeks. If your team is already saturated, fix that first.

Signs you are not — yet

1. You are expanding to escape a home-market problem. Weak domestic sales usually signal a product or positioning issue. New markets amplify problems; they do not solve them.

2. No one owns export. If international expansion is everyone’s side project, it is no one’s job. The market notices.

3. Your service concept ends at the border. “The customer can ship the unit back to us” is not an answer a hospital or research institute will accept. Solve service before the first sale, not after the first failure.

Readiness is not about company size. Ten-person manufacturers expand successfully every year — because they expand deliberately.

Score yourself honestly against these eight. Five green lights and zero red ones is a genuine go-signal — and the moment when talking to a local partner stops being theoretical.

“We will represent you locally” is an easy sentence to say and a vague one to buy. So here is the concrete version: what actually happens in the first 90 days of a representation engagement, and what you should expect from any partner you consider — including us.

Days 1–30: Foundation

The first month is unglamorous by design. The partner works through your technical documentation until they can answer first-line questions without calling you. Certification and import requirements are checked against the target market, and gaps are listed with costs and timelines. Your pricing is stress-tested against local competition and buying power. And the first target list is built: named institutions, named departments, named people — not “the pharmaceutical sector.”

What you should receive: a written market assessment, a compliance gap list, and a target list you can challenge.

Days 31–60: First contact

Outreach begins — emails and calls in the local language, referencing the recipient’s actual work, offering something specific: a demonstration, a sample measurement, a technical conversation. In parallel, the partner registers on relevant tender portals and starts the monitoring routine. Early conversations produce the first real market feedback: which claims resonate, which competitor is entrenched where, what price reaction looks like.

What you should receive: an outreach log with response rates, and unfiltered feedback — including the uncomfortable parts.

Days 61–90: First meetings and an honest verdict

The pipeline gets its first real entries: meetings held, demos scheduled, a tender identified, perhaps a first quote requested. Just as important, the partner now knows enough to tell you the truth about the market — realistic deal sizes, sales-cycle length, and whether the entry model you chose still fits what they learned.

What you should receive: a pipeline review and a written recommendation for the next two quarters — even if that recommendation is “adjust course.”

What 90 days does not deliver

Signed purchase orders, usually. Instruments with five- and six-figure prices have quarters-long sales cycles, and any partner promising closed deals in ninety days is telling you what you want to hear. What 90 days must deliver is verifiable motion: named contacts, held meetings, logged feedback, and a pipeline you can audit.

Judge a local partner the way you judge an employee in their first quarter: not on miracles, but on visible, documented progress you can check.

If a partner cannot describe their first 90 days at this level of detail before you sign — that, too, is information.